Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Gelen, T.
Right arrow Articles by Keles, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gelen, T.
Right arrow Articles by Keles, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Japanese Journal of Clinical Oncology 33:346-352 (2003)
© 2003 Foundation for Promotion of Cancer Research

p27 Labeling Index and Proliferation in Gastrointestinal Stromal Tumors: Correlations with Clinicopathologic Factors and Recurrence

Tekinalp Gelen1, Gülsüm Özlem Elpek1, Nazif Hikmet Aksoy1, Mehmet Ögüs2 and Nuran Keles1,+,§

1 Department of Pathology and 2 Department of General Surgery, Akdeniz University, Medical School, Antalya, Turkey

Background: Low expression of p27, a cyclin-dependent kinase inhibitor, has recently been reported to be associated with poor prognosis of many tumors. Moreover, an inverse relationship between p27 expression and proliferation was also noted. Although accumulating data indicate a correlation between high proliferation rate and aggressive behavior of gastrointestinal stromal tumors, no conclusive correlation between p27 expression and either tumor recurrence or proliferation has been established yet in this disease. The aim of this study was to immunohistochemically investigate the association of p27 expression (as measured by the p27 labeling index: p27LI) with recurrence and proliferation (as measured by the Ki-67 labeling index: KLI) in gastrointestinal stromal tumors.

Methods: p27LI and KLI were investigated in tumor specimens from 50 patients diagnosed with gastrointestinal stromal tumors. Quantitative evaluations of p27LI and KLI were performed on tissue sections stained immunohistochemically with anti-p27 and anti-Ki-67 monoclonal antibodies.

Results: Both p27LI and KLI were associated with the presence of recurrence and high mitotic index. A significant inverse correlation was noted between p27LI and KLI (r = –0.82). The recurrence-free survival time was significantly shorter in patients with high KLI (>=10%), low p27LI (<18%), mitosis (>=4), and larger tumor size (>=5.2cm). Multivariate analysis indicated that p27LI, KLI, and mitosis were independent predictors of recurrence-free survival.

Conclusions: These findings support the view that p27LI is a reliable marker in predicting recurrence and recurrence-free survival in gastrointestinal stromal tumors. Moreover, the concordance of high KLI together with low p27LI, and vice versa, might allow us to measure the aggressiveness of these tumors.

+ For reprints and all correspondence: Gülsüm Özlem Elpek, Akdeniz Üniversitesi, Tip Fakültesi, Patoloji ABD, Yeni Tip, Dekanlik, 07070, Antalya, Turkey. E-mail: elpek{at}med.akdeniz.edu.tr

§ Abbreviations: GIST, Gastrointestinal stromal tumors; P27LI, p27 labeling index; KLI, Ki-67 labeling index; MI, mitotic index


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.